Skip to main content


Back to About Us
Back to Mercy Hospital

Medication Safety

Overview

This rotation will provide the resident knowledge and experience to identify, develop and implement safe medication practices. The resident will gain knowledge through reading articles and publications on mediation safety. The knowledge will then be applied to develop and implement initiatives to improve the medication use system. The resident will work with the manager of performance improvement and members of the Medication Safety Steering Committee which include Executive Vice Presidents, Directors, and Managers across Mercy & Unity. In addition the resident will work with the Nursing/Pharmacy Committee.  

Preceptor
Lance L. Swearingen, M.S., R.Ph
Manager Performance Improvement

Contact information
Pager: (612) 654-3369 
Phone: (763) 236-4690
Fax (763) 236-4143 
E-mail Lance.Swearingen@allina.com

Rotation location
Mercy & Unity Hospitals

Hours
Monday - Friday
(Approximate) 0800-1630


Goals

Goal S1:Take personal responsibility for attaining excellence in one’s own ability to provide pharmaceutical care.
Goal S2: Demonstrate ethical conduct in all job-related activities.
Goal S3: Demonstrate the characteristics of a professional.
Goal S6: Use an organized system for staying current with pertinent literature.
Goal S7: Communicate clearly when speaking or writing.
Goal S19: Manage time effectively to fulfill practice responsibilities.
Goal P6: Participate in the components of disease management: identification of need for, and development, implementation and assessment of, treatment guidelines/protocols related to individual and population-based patient care.
Goal P7: Exercise leadership in the health system's continuous quality improvement (CQI) approach to designing a process to prevent medication misadventures and to identify, assess, and manage those that occur.
Goal P9: Participate in the medication-use evaluation (MUE) program in a health system.
Goal P10: Help ensure the health system's ongoing adherence to its medication-use policies.
Goal P12: Understand a process for formulating and delivering programs
Goal M3: Participate in the health system's formulary process.
Goal M4: Participate in the development or modification of policies for the use of medications in a health system.
Goal M5: Understand the principles of a systematic approach to staff development in pharmacy practice.
Goal M6: Work through the political and decision-making structure to accomplish one's practice area goals.
Goal M8: Participate in clinical, humanistic and economic outcomes analyses.
Goal M9: Understand the process of managing the practice area's human resources.
Goal M10: Understand steps that must be taken to ensure departmental compliance with accreditation, legal, regulatory, and safety requirements
Goal M13: Participate in the departmental performance improvement program.

Daily rotation activities

The resident will assist in the development of policy and/or initiatives aimed at reducing medication errors within the organization. The resident will be assigned projects at the beginning of the month to complete. Projects will be designed to improve the safety of the medication use system. This may include the prescribing, dispensing, administering, monitoring or inventory management phases of the medication use system. In addition, the resident will meet routinely with the preceptor to discuss topics related to medication safety.

Interaction with healthcare providers

The resident will interact with the pharmacy manager for performance improvement and pharmacists at both Mercy & Unity Hospitals. In addition the resident will interact with physicians, healthcare executive vice presidents, and other leaders of pharmacy in the twin cities area focused on medication safety.

Meeting attendance

The resident will set up a meeting weekly with the preceptor for 30 minutes. These meetings will allow time for the preceptor to review rotation activities from the previous week and provide feedback on performance. The resident will also set up a meeting on the last day of the rotation to review the preceptor and resident evaluation. Additional meetings include attending the pharmacist meetings, Continuing Medical Education Seminar, Hospitalist Care Improvement Seminar, Leading Edge Educational Seminar, P&T Committee (if applicable), Medication Safety Steering Committee and Safest in America.

Topics/disease states for discussion

  • Institute for Healthcare Improvement
  • Institute for Safe Medication Practices
  • Institute of Medicine Report: To Err is Human (focus on Chapter 8)
  • Building System Safeguards for the Safe Use of High Alert Medications
  • Adverse Events (ADR’s and ADE’s)
  • Joint Commission 2003 and 2004 Patient Safety Goals
  • Joint Commission Accreditation Manual: Medication Management Section 
  • Bates DW, Cullen DJ, Laird N, et. al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. JAMA 1995;274:29-34
  • Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events. JAMA 1995;274:35-43.

Orientation to the rotation - the preceptor will:

  • Provide the resident the goals and objectives for the learning experience
  • List the activities the resident will be engaged in during the month to accomplish the goals and objectives (see step 7 of the RLS process)
  • Describe how the preceptor will evaluate the resident (e.g., objective data, criteria based checklist)
  • Provide the resident with self evaluation forms (e.g., rotation evaluation from, criteria based checklist), and
  • Communicate how will the resident evaluate the preceptor
  • Establish routine meetings during the month to provide feedback and allow time for clarifying expectations. Monitor the growth and development of the resident during this time.


Back to Pharmacy Practice Residency Program
 

 

Mercy & Unity Hospitals
Pharmacy Residency Program
550 Osborne Road
Fridley, MN 55432
763-236-4690
E-mail us

 

back to top Back to Top

This site is presented for information only and is not intended to substitute for professional medical advice.
Allina®, the Allina logo, and Medformation® are registered trademarks of Allina Health System.
Presentation and Design ©2010 Allina Health System. All Rights Reserved.